In Novosibirsk, an alcohol-based drug has been created for treating heart rhythm disorders
The National Medical Research Center named after Meshalkin has developed a drug based on ethyl and isobutyl alcohols for treating arrhythmias. Preclinical trials have been completed, the first phase of clinical research is provisionally scheduled for mid-November, and market entry is possible in 2029–2030.
Otabek Yusupov